• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchElevation Oncology
    Picture of Elevation Oncology logo

    ELEV — Elevation Oncology News Story

    $0.380.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapValue Trap
    • Market Cap
      $22.22m
    • Enterprise Value
      -$27.19m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ELEV Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ELEV Dividends
    All News

    NASDAQ RESUMED AT 01:09 PM

    Picture of Elevation Oncology logoElevation Oncology
    25/06/2021 18:09
    NASDAQ RESUMED  ELEV.O  AT 01:09 PM
    

    Recent news on Elevation Oncology

    See all news
    • Brief: Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical

      02/07/2025 21:20
    • U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex

      10/06/2025 08:17
    • Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR

      09/06/2025 13:43
    • Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview

      28/04/2025 13:58
    • Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing

      04/04/2025 22:59

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.